Resource Center

White Paper
Why are My Medicaid Rebates So High?

Why are My Medicaid Rebates So High?

Have you found yourself asking, "Why are my Medicaid rebates so high?" You're not alone. Many of our clients pose this very question. To help you understand and manage your Medicaid rebate liability, we examine three critical areas. This white paper will guide you...

Prescription Drug Line Extensions: URA, Rebates & 340B

Prescription Drug Line Extensions: URA, Rebates & 340B

For pharmaceutical manufacturers acquiring or launching brand drugs, line extensions remain a topic fraught with frequent inquiries and complexities. Line extensions, with their unique formulas to determine the Unit Rebate Amount (URA), can often be a source of...

Top 3 Reasons Your AMP Changed

Top 3 Reasons Your AMP Changed

Top 3 Reasons Your AMP ChangedLarge variances in Average Manufacturer Price (AMP) values are a common source of inquiry for pharmaceutical manufacturers. Questions often arise when internal stakeholders are trying to understand an undesired rebate liability or a...

Emerging Drug Price Disclosure Legislation – April 2020

Emerging Drug Price Disclosure Legislation – April 2020

Continued Emergence of Drug Price Disclosure LegislationTips for staying compliant with an accelerating trendStates Have Gotten Aggressive with Fines Against Pharma Companies for Price Reporting Noncompliance This paper, our third in a series that looks at the rising...